News

CVS Health Has Become A Strong GARP Pick (Rating Upgrade)
Current parameters surrounding CVS Health represent a biased reward/risk ratio. Click here to see why I upgraded my rating of ...
Novo Nordisk's Moat Is Deeper Than You Think
Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...